Green Cross Corporation (006280.KS)
KRW 168000.0
(-1.7%)
KRW 168000.0
(-1.7%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -26.63 Billion KRW | -140.69% |
| 2022 | 65.45 Billion KRW | -46.88% |
| 2021 | 123.21 Billion KRW | 52.02% |
| 2020 | 81.04 Billion KRW | 818.05% |
| 2019 | -11.28 Billion KRW | -132.78% |
| 2018 | 34.42 Billion KRW | -35.34% |
| 2017 | 53.24 Billion KRW | -15.44% |
| 2016 | 62.96 Billion KRW | -33.69% |
| 2015 | 94.96 Billion KRW | 13.13% |
| 2014 | 83.94 Billion KRW | 19.81% |
| 2013 | 70.06 Billion KRW | 30.62% |
| 2012 | 53.64 Billion KRW | -3.11% |
| 2011 | 55.36 Billion KRW | -47.11% |
| 2010 | 104.68 Billion KRW | 30.01% |
| 2009 | 80.52 Billion KRW | 64.76% |
| 2008 | 48.87 Billion KRW | 10.18% |
| 2007 | 44.35 Billion KRW | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -9.1 Billion KRW | 64.05% |
| 2024 Q1 | -25.31 Billion KRW | -27.4% |
| 2024 Q3 | 35.8 Billion KRW | 465.52% |
| 2023 Q1 | -22.12 Billion KRW | -1070.62% |
| 2023 Q2 | 2.68 Billion KRW | 112.11% |
| 2023 FY | -26.63 Billion KRW | -140.69% |
| 2023 Q4 | -19.86 Billion KRW | -242.72% |
| 2023 Q3 | 13.92 Billion KRW | 419.45% |
| 2022 Q3 | 37.5 Billion KRW | 189.9% |
| 2022 Q4 | -1.89 Billion KRW | -105.04% |
| 2022 Q2 | 12.93 Billion KRW | -28.24% |
| 2022 FY | 65.45 Billion KRW | -46.88% |
| 2022 Q1 | 18.02 Billion KRW | -65.13% |
| 2021 Q2 | 3.04 Billion KRW | -79.41% |
| 2021 Q4 | 51.7 Billion KRW | -3.71% |
| 2021 FY | 123.21 Billion KRW | 52.02% |
| 2021 Q3 | 53.7 Billion KRW | 1666.47% |
| 2021 Q1 | 14.76 Billion KRW | 0.06% |
| 2020 FY | 81.04 Billion KRW | 818.05% |
| 2020 Q1 | -4.31 Billion KRW | 81.0% |
| 2020 Q4 | 14.75 Billion KRW | -75.78% |
| 2020 Q3 | 60.91 Billion KRW | 528.21% |
| 2020 Q2 | 9.69 Billion KRW | 324.54% |
| 2019 Q2 | -9.2 Billion KRW | -285.2% |
| 2019 FY | -11.28 Billion KRW | -132.78% |
| 2019 Q1 | 4.96 Billion KRW | 395.93% |
| 2019 Q3 | 23.32 Billion KRW | 353.42% |
| 2019 Q4 | -22.72 Billion KRW | -197.44% |
| 2018 Q2 | 3.8 Billion KRW | -75.74% |
| 2018 Q4 | -1.67 Billion KRW | -110.11% |
| 2018 FY | 34.42 Billion KRW | -35.34% |
| 2018 Q1 | 15.68 Billion KRW | 532.9% |
| 2018 Q3 | 16.61 Billion KRW | 336.56% |
| 2017 Q4 | -3.62 Billion KRW | -113.39% |
| 2017 Q3 | 27.05 Billion KRW | 7.3% |
| 2017 Q1 | 4.59 Billion KRW | -76.1% |
| 2017 FY | 53.24 Billion KRW | -15.44% |
| 2017 Q2 | 25.21 Billion KRW | 448.63% |
| 2016 FY | 62.96 Billion KRW | -33.69% |
| 2016 Q3 | 22.39 Billion KRW | 39.24% |
| 2016 Q2 | 16.08 Billion KRW | 205.42% |
| 2016 Q1 | 5.26 Billion KRW | 273.62% |
| 2016 Q4 | 19.22 Billion KRW | -14.13% |
| 2015 FY | 94.96 Billion KRW | 13.13% |
| 2015 Q4 | -3.03 Billion KRW | -105.29% |
| 2015 Q3 | 57.3 Billion KRW | 102.61% |
| 2015 Q2 | 28.28 Billion KRW | 127.8% |
| 2015 Q1 | 12.41 Billion KRW | 995.37% |
| 2014 FY | 83.94 Billion KRW | 19.81% |
| 2014 Q4 | -1.38 Billion KRW | -103.09% |
| 2014 Q3 | 44.93 Billion KRW | 266.79% |
| 2014 Q2 | 12.25 Billion KRW | -56.46% |
| 2014 Q1 | 28.13 Billion KRW | 1678.42% |
| 2013 Q3 | 33.6 Billion KRW | 112.88% |
| 2013 Q4 | 1.58 Billion KRW | -95.29% |
| 2013 Q1 | 19.09 Billion KRW | 410.11% |
| 2013 FY | 70.06 Billion KRW | 30.62% |
| 2013 Q2 | 15.78 Billion KRW | -17.35% |
| 2012 Q3 | 32.62 Billion KRW | 186.99% |
| 2012 FY | 53.64 Billion KRW | -3.11% |
| 2012 Q4 | -6.15 Billion KRW | -118.88% |
| 2012 Q1 | 15.8 Billion KRW | 1665.11% |
| 2012 Q2 | 11.36 Billion KRW | -28.09% |
| 2011 FY | 55.36 Billion KRW | -47.11% |
| 2011 Q4 | -1.01 Billion KRW | -103.04% |
| 2011 Q2 | 10.44 Billion KRW | -17.89% |
| 2011 Q1 | 12.71 Billion KRW | 0.0% |
| 2011 Q3 | 33.2 Billion KRW | 218.09% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 Q2 | 16.3 Billion KRW | -74.95% |
| 2010 Q1 | 65.07 Billion KRW | 51.14% |
| 2010 FY | 104.68 Billion KRW | 30.01% |
| 2010 Q3 | 29.43 Billion KRW | 80.52% |
| 2009 Q1 | 7.69 Billion KRW | -22.11% |
| 2009 Q3 | 15.31 Billion KRW | 5.84% |
| 2009 Q4 | 43.05 Billion KRW | 181.2% |
| 2009 Q2 | 14.46 Billion KRW | 88.09% |
| 2009 FY | 80.52 Billion KRW | 64.76% |
| 2008 Q3 | 9.85 Billion KRW | -47.38% |
| 2008 FY | 48.87 Billion KRW | 10.18% |
| 2008 Q1 | 10.4 Billion KRW | 191.36% |
| 2008 Q2 | 18.73 Billion KRW | 80.12% |
| 2008 Q4 | 9.87 Billion KRW | 0.16% |
| 2007 FY | 44.35 Billion KRW | 0.0% |
| 2007 Q1 | 10.1 Billion KRW | 0.0% |
| 2007 Q2 | 13.67 Billion KRW | 35.3% |
| 2007 Q3 | 17 Billion KRW | 24.35% |
| 2007 Q4 | 3.57 Billion KRW | -79.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| ORIENT BIO Inc. | 12.87 Billion KRW | 306.912% |
| Green Cross Holdings Corporation | -54.13 Billion KRW | 50.806% |
| Green Cross Holdings Corporation | -26.63 Billion KRW | -0.0% |
| Pharmicell Co., Ltd. | 3.57 Billion KRW | 844.324% |
| GeneOne Life Science, Inc. | -77.76 Billion KRW | 65.755% |
| Celltrion, Inc. | 535.64 Billion KRW | 104.972% |
| Samsung Biologics Co.,Ltd. | 857.69 Billion KRW | 103.105% |
| SK bioscience Co.,Ltd. | 22.31 Billion KRW | 219.33% |
| SK Biopharmaceuticals Co., Ltd. | -32.88 Billion KRW | 19.01% |
| Prestige BioPharma Limited | -32.92 Billion KRW | 19.105% |